Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000640891 | SCV000762495 | benign | Menkes kinky-hair syndrome; Cutis laxa, X-linked; X-linked distal spinal muscular atrophy type 3 | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001756068 | SCV001985723 | uncertain significance | not provided | 2023-03-13 | criteria provided, single submitter | clinical testing | Has been reported in at least one individual with ataxia, dystonia, spasticity and/or an extrapyramidal movement disorder in published literature (Bansagi et al., 2016; Bansagi et al., 2017); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28251916, 27878136, 34426522, 33210134) |
Ambry Genetics | RCV002449008 | SCV002733330 | likely benign | Inborn genetic diseases | 2021-08-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001756068 | SCV003834469 | uncertain significance | not provided | 2023-03-08 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000640891 | SCV001457710 | uncertain significance | Menkes kinky-hair syndrome; Cutis laxa, X-linked; X-linked distal spinal muscular atrophy type 3 | 2020-09-16 | no assertion criteria provided | clinical testing | |
Solve- |
RCV004768496 | SCV005091499 | likely pathogenic | X-linked distal spinal muscular atrophy type 3 | 2022-06-01 | no assertion criteria provided | provider interpretation | Variant confirmed as disease-causing by referring clinical team |